February 12, 2025

Can Skin Patches Ease Prostate Therapy?

A phase 2 trial presents promising findings on the effectiveness of transdermal estradiol patches in delivering part of the androgen deprivation therapy for prostate cancer patients, showing potential in reducing adverse effects.

Reuters

June 19, 2023

Aromatase Inhibitors May Limit Effectiveness of Weight Loss Medications in Breast Cancer Survivors

Aromatase inhibitors may interfere with the efficacy of weight loss medications in breast cancer survivors, according to a new study presented by Fansa et al at the 2023 Endocrine Society Annual Meeti...

The ASCO Post

June 05, 2024

Impact of High Blood Insulin Levels on Triple-Negative Breast Cancer Survival in Black Women

High blood insulin levels may contribute to worse outcomes in Black women with triple-negative breast cancer, according to new findings presented at the Endocrine Society’s Annual Meeting & Exposi...

The ASCO Post

June 27, 2024

Analysis Evaluates Safety Profile of Enobosarm

A pooled analysis revealed insights on adverse events experienced by patients taking enobosarm, a selective androgen receptor modulator, vs a placebo.

Conexiant

September 09, 2024

Bariatric Surgery Outperformed Meds for Hypertension Control

Meta-analysis reveals bariatric surgery patients 7 times more likely to reduce antihypertensive medications compared to conventional treatment.

Conexiant

November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

December 02, 2024

Can Hidden Fat Predict Alzheimer's Risk?

A study presented at RSNA 2024 demonstrated findings at midlife, decades prior to patients exhibiting early symptoms of Alzheimer's disease related dementia.

Conexiant

July 01, 2024

Mediterranean & DASH Diets May Lower Cardiovascular Risk in T1D

More closely following Mediterranean or DASH diets may be linked to lower cardiovascular disease risk

Conexiant

June 21, 2024

Salsalate for T1D Neuropathy: Phase 2 Trial Results

Can an old drug learn new tricks?

Conexiant